Professor
University of British Columbia
Vancouver, British Columbia, Canada
Megan K. Levings, PhD
Professor, Department of Surgery and School of Biomedical Engineering, University of British Columbia
Canada Research Chair in Engineered Immune Tolerance
Lead, Childhood Diseases Theme, BC Children’s Hospital Research Institute
Dr. Megan Levings is a Professor in the Department of Surgery and School of Biomedical Engineering at the University of British Columbia and BC Children’s Hospital Research Institute. Her lab studies how a special kind of white blood cell, known as a T regulatory cell, could be used as a cellular therapy to stop harmful immune responses. She is internationally recognized in the field of human immunology and leads a vibrant group of trainees and staff who are researching how to use T regulatory cells to replace conventional immunosuppression in the context of transplantation and autoimmunity. She has won numerous awards, including 2020 YWCA Woman of Distinction, Science, Research & Technology, 2022 Simon Fraser University Outstanding Alumni award, and 2022 UBC Faculty of Medicine Distinguished Researcher in the Basic/Foundational Science Category.
Disclosure information not submitted.
Immune Responses to GT/Therapeutics
Wednesday, June 19, 2024
1:00 PM – 2:45 PM PT
Engineering Regulatory T Cells for Tolerance
Thursday, June 20, 2024
2:20 PM – 2:45 PM PT
